Christiana Stamoulis, SVP, Corporate Strategy & Business Devlp at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 602 shares at $79.48 ($48K) on 2013-05-15, disclosed to the SEC on 2013-05-17.
Scheduled sale ($48k) by SVP, Corporate Strategy & Business Devlp under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $79.48 | 502 | $40K | 83.2% |
| 2 | $80.50 | 100 | $8K | 16.8% |
| Total | $79.65 avg | 602 | $48K | 100% |
| Filing → |
| HOLX | SELL | 2020-11-06 | $825K | — | Filing → |
| HOLX | SELL | 2019-11-26 | $1.2M | — | Filing → |
| HOLX | SELL | 2018-11-30 | $1.2M | — | Filing → |